DeBakey CV Journal: Cardiovascular Pharmacology - Miguel Quiñones & Albert Raizner 1.24.23

** This medical education program may contain graphic content. ** _________________________________ A DeBakey CV Education event Presented by Houston Methodist DeBakey Heart & Vascular Center. Building on Dr. Michael E. DeBakey’s commitment to excellence in education, Houston Methodist DeBakey CV Education is an epicenter for cardiovascular academic and clinical educational programs that support the provision of optimal care to patients suffering from cardiovascular conditions and diseases. FOR MORE INFORMATION DeBakey CV Education: https://www.houstonmethodist.org/educ... For the latest education and training opportunities from DeBakey CV Education: http://bit.ly/HMdebakeyemail Follow Us: Facebook:   / debakeycvedu   Twitter:   / debakeycvedu   Livestream: https://livestream.com/debakey SmugMug: https://debakey.smugmug.com/ Want concise, relevant reviews of the hottest topics in CV medicine? Subscribe for FREE to the Methodist DeBakey Cardiovascular Journal for quarterly, peer-reviewed issues delivered to your door. https://journal.houstonmethodist.org/

GDMT for HFPEF: Are We There Yet? (Dr. Muthiah Vaduganathan)
▶︎

GDMT for HFPEF: Are We There Yet? (Dr. Muthiah Vaduganathan)

Precision Cardiovascular Disease Prevention (Dr. Pradeep Natarajan)
▶︎

Precision Cardiovascular Disease Prevention (Dr. Pradeep Natarajan)

Basic Cardiovascular Pharmacology (Schell)
▶︎

Basic Cardiovascular Pharmacology (Schell)

How to Fall in Love with Someone | Yale Conversations with David Brooks | Yale University
▶︎

How to Fall in Love with Someone | Yale Conversations with David Brooks | Yale University

Heart Failure 2026 - Reviewing CCS 2025 Heart Failure Guidelines
▶︎

Heart Failure 2026 - Reviewing CCS 2025 Heart Failure Guidelines

DeBakey CV Journal: The Kidney & The Heart - Hassan Ibraham & Miguel Quinones 9.29.22
▶︎

DeBakey CV Journal: The Kidney & The Heart - Hassan Ibraham & Miguel Quinones 9.29.22

Therapeutic Challenges inArrhythmogenic Cardiomyopathy:An Electrophysiology Perspective -Dr. Michaud
▶︎

Therapeutic Challenges inArrhythmogenic Cardiomyopathy:An Electrophysiology Perspective -Dr. Michaud

Cardiovascular Pharmacology
▶︎

Cardiovascular Pharmacology

Dr. Nadir Ali - 'Do statins prevent or cause heart disease? Should LDL be called "bad" Cholesterol?'
▶︎

Dr. Nadir Ali - 'Do statins prevent or cause heart disease? Should LDL be called "bad" Cholesterol?'

Cardiology’s Credibility Crisis And the Revolution Within Reach (Dr. Robert Yeh)
▶︎

Cardiology’s Credibility Crisis And the Revolution Within Reach (Dr. Robert Yeh)

Read The Korea Economic Daily in 30 Minutes | 20260511🌞#MorningRoutine
▶︎

Read The Korea Economic Daily in 30 Minutes | 20260511🌞#MorningRoutine

Tax Considerations for Reg CF & Reg A Investors: QSBS, K-1s, Losses, and What the Crowd Should Know
▶︎

Tax Considerations for Reg CF & Reg A Investors: QSBS, K-1s, Losses, and What the Crowd Should Know

Beta Blockers | Cardiovascular Pharmacology
▶︎

Beta Blockers | Cardiovascular Pharmacology

Assessment of Diastolic Function: 2025 Guidelines (Dr. Sherif Nagueh)
▶︎

Assessment of Diastolic Function: 2025 Guidelines (Dr. Sherif Nagueh)

Michigan Cardiac Rehab Network (MiCR) Telehealth Forum - June 9th, 2026
▶︎

Michigan Cardiac Rehab Network (MiCR) Telehealth Forum - June 9th, 2026

Atrial Fibrillation: ALCOHOL, CAFFEINE, APPLE WATCHES
▶︎

Atrial Fibrillation: ALCOHOL, CAFFEINE, APPLE WATCHES

LVAD Emergencies and Basics (Ju Kim, MD) July 22, 2020
▶︎

LVAD Emergencies and Basics (Ju Kim, MD) July 22, 2020

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Clinical Case Discussions: Qualified Autologous Serum Eye Drops (Q-ASEDs) in Ocular Surface Disease
▶︎

Clinical Case Discussions: Qualified Autologous Serum Eye Drops (Q-ASEDs) in Ocular Surface Disease

Basic Cardiovascular Pharmacology (Schell)
▶︎

Basic Cardiovascular Pharmacology (Schell)